Counterfeit Version of Avastin In U.S. Distribution

The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.

The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy. 

Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.

Click here for FDA announcement.

 

Share |
January 14, 2015 03:20 PM
An interview with Max Wallace, CEO of Accelerate Brain Cancer Cure.
January 7, 2015 06:26 PM
Max Wallace, CEO of ABC², responds to the op-ed piece by Llewellyn Hinkes-Jones published this week in the New York Times. 
December 4, 2014 02:02 PM
Concert proceeds benefit Accelerate Brain Cancer Cure.

Join us in our fight for a cure!

Twitter